Napredna pretraga

Pregled bibliografske jedinice broj: 36894

The expression and role of insulin-like growth factor II in malignant hemangiopericytomas


Pavelić, Krešimir; Spaventi, Šime; Glunčić, Vicko; Matejčić, Aljoša; Pavičić, Dino; Karapandža, Nikola; Kusić, Zvonimir; Lukač, Josip; Dohoczky, Csaba; Čabrijan, Tomislav; Pavelić, Jasminka
The expression and role of insulin-like growth factor II in malignant hemangiopericytomas // Journal of molecular medicine - JMM, 77 (1999), 12; 865-869 (međunarodna recenzija, članak, znanstveni)


Naslov
The expression and role of insulin-like growth factor II in malignant hemangiopericytomas

Autori
Pavelić, Krešimir ; Spaventi, Šime ; Glunčić, Vicko ; Matejčić, Aljoša ; Pavičić, Dino ; Karapandža, Nikola ; Kusić, Zvonimir ; Lukač, Josip ; Dohoczky, Csaba ; Čabrijan, Tomislav ; Pavelić, Jasminka

Izvornik
Journal of molecular medicine - JMM (0946-2716) 77 (1999), 12; 865-869

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Hemangiopericytoma; insulin-like growth factor II; insulin-like growth factor I receptor

Sažetak
Hemangiopericytoma is a rare soft tissue tumor originating from contractile pericapillary pericytes. To address the issue of molecular genetic events that participate in genesis and progression of hemangiopericytoma, we analysed insulin-like growth factor II and insulin-like growth factor I receptor in 29 tumors collected from a human tumor bank network. Among them, seven tumors were associated with severe hypoglycemia. Of these, six tumors were retroperitoneal and one was located in the leg. Twelve out of twenty two (54.5%) tumors tested exhibited insulin-like growth factor II mRNA whereas almost 90% (17 out of 19) of hemangiopericytomas exhibited insulin-like growth factor I receptor mRNA. Sera from some patients whose tumors expressed insulin-like growth factor II mRNA contained elevated level of insulin-like growth factor II. Removal of the tumor eliminated most of the insulin-like growth factor II immunoreactivity from the sera. The potential role of insulin-like growth factor II as a growth promoting factor was examined on three malignant primary hemangiopericytoma cell cultures. Extracellular addition of insulin-like growth factor II significantly enhanced cell proliferation in a dose-dependent manner. Antisense oligodeoxynucleotides that specifically inhibit insulin-like growth factor II mRNA, in concentration of 40 or 80 mg/ml, inhibited the growth of hemangiopericytoma cells significantly - by 40%. Simultaneous application of antisense deoxyoligonucleotides to both insulin-like growth factor II and insulin-like growth factor I receptor inhibited tumor cell proliferation by even 80%. Our data suggest that tumor cells produce insulin-like growth factor II which in turn stimulate their proliferation by autocrine mechanisms.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE